definiens: as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding theresearch, development and commercialization of pharmaceutical products . Such forward - looking statements are based on current expectations and involveinherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differmaterially from current expectations . No forward - looking statement can be guaranteed . Among other risks, there can be no guarantee that the compounddiscussed in this release, either alone or in combination with Opdivo or Yervey, will be successfully developed or approved for any of the indicationsdescribed in this release . Forward - looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol - Myers Squibb 's business, particularly those identified in the cautionary factors discussion in Bristol - Myers Squibb 's Annual Report on Form 10 - K for the yearended December 31, 2015 in our Quarterly Reports on Form 10 - Q and our Current Reports on Form 8 - K. Bristol - Myers Squibb undertakes no obligation topublicly update any forward - looking statement, whether as a result of new information, future events or otherwise